| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |